Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 
Home   |   Customers   |   Vendors   |   Libraries  

  FDsys > Browse By Collection > Collection Results > More Information
(Search string is required)
 

77 FR 62520 - Prospective Grant of Exclusive License: The Development of Anti-CD22 Chimeric Antigen Receptors (CARs) for the Treatment of B Cell Malignancies


Download Files

Metadata

Document in Context
This is part of Federal Register Volume 77, Issue 199 (October 15, 2012)
View Entire Issue